We are live on ! Find out more
ONCY

Oncolytics Biotech
ONCY

37 hedge funds and large institutions have $2.79M invested in Oncolytics Biotech in 2021 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 8 increasing their positions, 8 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 8

0.02% less ownership

Funds ownership: 1.93% → 1.91% (-0.02%)

16% less funds holding

Funds holding: 44 → 37 (-7)

18% less capital invested

Capital invested by funds: $3.39M → $2.79M (-$600K)

78% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 9

Holders
37
Holders Change
-7
Holders Change %
-15.91%
% of All Funds
0.65%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
8
Reduced
8
Closed
9
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
+$423K
2
Morgan Stanley
Morgan Stanley
New York
+$83.5K
3
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
+$75.8K
4
NDSI
Newman Dignan & Sheerar Inc
Rhode Island
+$29.2K
5
Geode Capital Management
Geode Capital Management
Massachusetts
+$22.9K

Top Sellers

Rank Fund Capital Flow
1
ARC
Advisor Resource Council
Texas
-$280K
2
TD Asset Management
TD Asset Management
Ontario, Canada
-$120K
3
Two Sigma Advisers
Two Sigma Advisers
New York
-$117K
4
VF
Virtu Financial
New York
-$98K
5
Two Sigma Investments
Two Sigma Investments
New York
-$70K
Name Holding Trade Value Shares
Change 		Change in
Stake
ZB
26
Zions Bancorporation
Utah
$10K – – –
FDCDDQ
27
Federation des caisses Desjardins du Quebec
Quebec, Canada
$6.95K – – –
Osaic Holdings
28
Osaic Holdings
Arizona
$6K -$3.4K -1,500 -34%
HI
29
Harbour Investments
Wisconsin
$5K – – –
Toronto Dominion Bank
30
Toronto Dominion Bank
Ontario, Canada
$3K -$2.93K -1,294 -50%
Wells Fargo
31
Wells Fargo
California
$3K – – –
Fifth Third Bancorp
32
Fifth Third Bancorp
Ohio
$2K – – –
SN
33
Sittner & Nelson
Oregon
$2K – – –
ARC
34
Advisor Resource Council
Texas
– -$280K -101,000 Closed
TD Asset Management
35
TD Asset Management
Ontario, Canada
– -$120K -52,007 Closed
VF
36
Virtu Financial
New York
– -$98K -35,425 Closed
Two Sigma Investments
37
Two Sigma Investments
New York
– -$70K -25,200 Closed
TCOV
38
Trust Company of Vermont
Vermont
– -$14K -5,000 Closed
TRCT
39
Tower Research Capital (TRC)
New York
– -$6K -2,160 Closed
RDWM
40
Red Door Wealth Management
Tennessee
– -$2K -1,000 Closed
1
2

ONCY Hedge Fund Activity: Q3 2021 in Review

37 of the 5,713 institutional investors tracked by Wall St. Rank reported a position in Oncolytics Biotech (ONCY) for Q3 2021, worth a combined $2.79M — down 18% from $3.39M a quarter earlier.

Sellers outnumbered buyers: 9 funds closed out of ONCY and 2 opened new positions — a net loss of 7 holders — while 8 trimmed existing stakes and 8 added.

The largest buyer was Renaissance Technologies, adding an estimated $423K. The largest seller was Advisor Resource Council, exiting entirely with an estimated $280K sold.

  • 37 institutional investors held Oncolytics Biotech (ONCY) as of Q3 2021, down from 44 in Q2 2021.
  • Funds reported $2.79M of Oncolytics Biotech stock for Q3 2021, down 18% quarter-over-quarter.
  • 2 funds opened new Oncolytics Biotech positions in Q3 2021 and 9 closed out, a net change of -7 holders.
  • The largest Oncolytics Biotech buyer in Q3 2021 was Renaissance Technologies, an estimated $423K added.
  • The largest Oncolytics Biotech seller in Q3 2021 was Advisor Resource Council, an estimated $280K sold.

Based on aggregated 13F filings for Q3 2021.